Marijuana advocates are arguing the DEA is playing politics with marijuana, for the benefit of the government and big Pharma all at the expense of average Americans. The DEA has recently reclassified THC, that pharmaceutical companies can push products with naturally derived formations of THC. Paul Armentano, Deputy Director of NORML explains.

Leave a Reply

Your email address will not be published. Required fields are marked *